About
Omicron
Omicron was founded by Søren Lophaven in August 2019 and aims at delivering top quality consultancy within biostatistics, statistical programming, epidemiology, real-world evidence and register-based research. I work with pharmaceutical companies, biotech and medical device companies and public institutions in Denmark, and collaborate with Damvad Analytics within the area of Real-world evidence. Omicron is a member of the Danish Society for Biopharmaceutical Statistics. I am financially supporting the R-project and will continue to promote the use of R in clinical development and epidemiology.
Services
Services
Biostatistics
All aspects of biostatistics, e.g. statistical analysis of clinical trial and real-world data, meta- and network meta-analyses, working on a Data Monitoring Committee (DMC)
Statistical Programming
I have worked with R for more than 15 years, with SAS for 25 years and with Matlab for 20 years. I am also improving my Python programming skills.
Epidemiology
Experience from a number of register studies within oncology, inflammatory bowel disease, dementia and Parkinson's disease.
Publications
Recent publications
Outcomes in GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting: The retrospective, observational EXPERT study. 2021.
In: Diabetes Therapy
Disease activity patterns, mortality and colorectal cancer risk in microscopic colitis: a Danish nationwide cohort study, 2001 to 2016. 2020.
In: Journal of Crohns and Colitis
Incidence and prevalence of microscopic colitis between 2001 and 2016: A Danish nationwide cohort study. 2020.
In: Journal of Crohns and Colitis
High incidence of dementia in Faroese-born female residents in Denmark. 2020.
In: Alzheimer's & Dementia: Translational Research & Clinical Interventions
Dietary risk factors for inflammatory bowel diseases in a high-risk population: Results from the Faroese IBD study. 2019.
In: United European Gastroenterology Journal
Full list of publications.
Presentations
Some presentations
Statistical Modelling
A very short introduction to R
DACE - a Matlab kriging toolbox
Model-based Estimation of Relative Risk
Diagnostic tests - Interpretation of results
Statistical Methods for Determining the Effect of Mammography Screening
Analysis and Visualization of Spatial and Spatio-temporal Data
Meta-analysis - Cranberry-containing products for prevention of urinary tract infections in susceptible populations
Visualising the expected population structure of Denmark 2019-2060 in R with ggplot2 and the animation package
Mapping the Ebola outbreak in R
Recent
News
Our manuscript entitled "Outcomes in GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting: The retrospective, observational EXPERT study" was published in Diabetes Therapy. Learn More.
I am giving a presentation about data management and statistics in clinical trials at atrium.
Our manuscript entitled "Disease activity patterns, mortality and colorectal cancer risk in microscopic colitis: a Danish nationwide cohort study, 2001 to 2016" was published in Journal of Crohns and Colitis. Learn More.
Our manuscript entitled "Incidence and prevalence of microscopic colitis between 2001 and 2016: A Danish nationwide cohort study" was published in Journal of Crohns and Colitis. Learn More.
Our manuscript entitled "High incidence of dementia in Faroese-born female residents in Denmark" was published in Alzheimer's & Dementia: Translational Research & Clinical Interventions. Learn More.
I am attending the celebRation workshop to mark the 20th anniversary of the release of R version 1.0.0.
I am attending the annual meeting of the Danish Society for Pharmacoepidemiology: The clinical implications of pharmacoepidemiological research.
Contact
Omicron
Address
Omicron ApS | CVR: 40668241
Søren Lophaven | Sankt Jørgens vej 15, 4000 Roskilde, Denmark
Phone
Email Address